HCPCS: Look For New HCPCS Codes with the CMS Quarterly Update

Why This Topic Matters

Quarterly HCPCS updates can affect claim submission, payment status, and reporting requirements for drugs, biologics, and outpatient services. Staying current helps reduce denials and supports accurate reimbursement workflows.

Article Sections

1. Drug and biological additions

   Introduces the update as a set of HCPCS changes centered on newly added drugs and biological products. It frames the main categories of code changes discussed in the article.

2. Relief for Chemo Patients with New HCPCS Addition

   Covers a newly added HCPCS drug code and the general clinical area associated with it. The section also notes the timing of the quarterly update and its outpatient context.

3. Other Q-Code changes

   Summarizes additional HCPCS Q-code additions included in the same update. It describes the broader subject area of the products involved and the effective date.

4. Watch for Modifier ZB with Biosimilar Change

   Discusses a biosimilar-related HCPCS update and a modifier reminder tied to claim submission. The section focuses on manufacturer differentiation and update timing.

5. Cost change

   Notes a pricing reassignment for a skin substitute product within the HCPCS update. It addresses the payment-related change and its effective date.

6. Take a Look at These C-Codes Updates

   Reviews outpatient prospective payment system pass-through status changes for several HCPCS C-codes. The section also includes a billing reminder related to discarded drug reporting.